Creative One Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Creative One Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $187,759 - $206,616	208 New	208 $200,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $4,763 - $5,788	-7 Reduced 2.13%	321 $264,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $26,117 - $28,356	37 Added 12.71%	328 $237,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $167,025 - $210,777	291 New	291 $200,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $195,760 - $263,765	-357 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $212,457 - $249,339	357 New	357 $249,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.